Source:http://linkedlifedata.com/resource/pubmed/id/20054520
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2010-3-23
|
pubmed:abstractText |
Regardless of the underlying disease, the proteinuric condition demonstrates ultrastructural changes in podocytes with retraction and effacement of the highly specialized interdigitating foot processes. To investigate how high-glucose (HG) and advanced glycosylation end products (AGE) induce podocyte phenotypical changes, including quantitative and distributional changes of zonula occludens (ZO)-1 protein and search for the signaling mechanisms, we cultured rat glomerular epithelial cells (GEpC) and mouse podocytes under: (1) normal glucose (5 mM, control); (2) HG (30 mM); (3) AGE-added; or (4) HG plus AGE-added conditions. HG plus AGE increased the permeability of monolayered GEpCs and induced ultrastructural separation between confluent GEpCs. ZO-1 moved to inner actin filament complexes in both AGE- and/or HG by confocal imaging. HG plus AGE-added condition also decreased ZO-1 protein amount and mRNA expression compared to normal glucose or osmotic control conditions. We could also confirm the induction of RAGE (receptor for AGE) and PI3-K/Akt signaling pathway by AGE and HG. In addition, LY294002, a PI3-K inhibitor, could prevent the quantitative and distributional changes of ZO-1 and RAGE and the increased permeability induced by HG and AGE. These findings suggest that diabetic conditions induce the podocyte ZO-1 changes via RAGE and PI3-K/Akt signaling, leading to increased permeability.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Glucose,
http://linkedlifedata.com/resource/pubmed/chemical/Glycosylation End Products, Advanced,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphoproteins,
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins c-akt,
http://linkedlifedata.com/resource/pubmed/chemical/zonula occludens-1 protein
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1432-1440
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
88
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
391-400
|
pubmed:dateRevised |
2011-7-8
|
pubmed:meshHeading |
pubmed-meshheading:20054520-Animals,
pubmed-meshheading:20054520-Enzyme Inhibitors,
pubmed-meshheading:20054520-Epithelial Cells,
pubmed-meshheading:20054520-Glucose,
pubmed-meshheading:20054520-Glycosylation End Products, Advanced,
pubmed-meshheading:20054520-Membrane Proteins,
pubmed-meshheading:20054520-Mice,
pubmed-meshheading:20054520-Microscopy, Confocal,
pubmed-meshheading:20054520-Models, Biological,
pubmed-meshheading:20054520-Permeability,
pubmed-meshheading:20054520-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:20054520-Phosphoproteins,
pubmed-meshheading:20054520-Podocytes,
pubmed-meshheading:20054520-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:20054520-Rats,
pubmed-meshheading:20054520-Signal Transduction
|
pubmed:year |
2010
|
pubmed:articleTitle |
High-glucose and advanced glycosylation end products increased podocyte permeability via PI3-K/Akt signaling.
|
pubmed:affiliation |
Department of Pediatrics, College of Medicine, Chungbuk National University, Gaeshin-dong 48, Heungdeok-gu, Cheongju, Chungbuk, 361-240, Korea. tsha@chungbuk.ac.kr
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|